Government: Page 121
-
FDA extends EpiPen expiration date to ease shortages
Current supply problems stemming from ongoing manufacturing delays could put children at risk as the school year approaches.
By Suzanne Elvidge • Aug. 22, 2018 -
CMS gives $8.6M to states to help stabilize ACA exchanges
Thirty states and the District of Columbia will receive less than $300,000 each from rate review grants established by the Affordable Care Act.
By Les Masterson • Aug. 21, 2018 -
Medicare overpaid millions for outpatient planning services
A report from the HHS Office of Inspector General blamed the excessive payments for intensity-modulated radiation therapy planning services mostly on hospitals not knowing or misinterpreting CMS guidance.
By Les Masterson • Aug. 21, 2018 -
Trump seeks federal opioid lawsuit, DOJ aims to slash manufacturing quotas
The president said he'd like Attorney General Jeff Sessions to launch a federal suit in addition to ongoing state legal actions. Meanwhile, the DOJ and DEA proposed further cuts to quotas on opioids for 2019.
By Andrew Dunn • Aug. 20, 2018 -
Health orgs aren't fully following IT safety advice, survey finds
Funding and personnel issues could contribute to systems not following through, according to the report published in the Journal of the American Medical Informatics Association.
By Les Masterson • Aug. 20, 2018 -
CMS touts quicker Medicaid waiver process
The agency said its efforts reduced administrative burdens for states and the government.
By Les Masterson • Aug. 20, 2018 -
Providence Health slapped with $188M False Claims Act lawsuit
The Renton, Washington-based health system is accused of adding spurious secondary diagnoses to Medicare claims to increase reimbursements.
By Meg Bryant • Aug. 17, 2018 -
Moving to electronic transactions could save Medicaid plans over $4.8B annually
A new report finds only 44% of Medicaid recipients are currently in plans with electronic claims processes.
By Les Masterson • Aug. 17, 2018 -
Payers transition to government health plans despite risks
Commercial health plans have dropped over the past 10 years as payers move to managed Medicaid and Medicare Advantage.
By Les Masterson • Aug. 16, 2018 -
Teva granted FDA approval for first EpiPen generic
It's the latest blow to Mylan, which came under fire for hiking EpiPen's price over the last decade and is now facing manufacturing challenges for the flagship product.
By David Lim • Aug. 16, 2018 -
Insurance brokers expect higher ACA plan premiums, market instability
Brokers predict more people will leave individual insurance for lower-cost options like short-term health plans and association health plans.
By Les Masterson • Aug. 16, 2018 -
FDA sets out vision to use real-world data in product evaluations
The agency wants insights into safety and efficacy outside of controlled research environments.
By Nick Paul Taylor • Aug. 16, 2018 -
Partial Medicaid expansion would restrict access for near-poor adults, study finds
Wisconsin is the only state so far to partially expand the program, but at least three other states are considering such a proposal, according to a Center on Budget and Policy Priorities report.
By Les Masterson • Aug. 15, 2018 -
Deep Dive
Prior authorization moves to EHRs
Manual prior authorization can create administrative burdens for practices and hospitals, but case studies show some success in making the process electronic.
By Les Masterson • Aug. 15, 2018 -
Nearly 20% of inpatient admissions include out-of-network charge
A Kaiser Family Foundation report found the issue of surprise billing is especially problematic for care in ERs and for psychological or substance abuse treatment.
By Les Masterson • Aug. 14, 2018 -
AHA continues to push HHS on Medicare billing backlog
AHA and three member hospitals are suing the agency and in the latest court filing suggested methods for reaching a court-ordered 2020 deadline for getting through the claims.
By Les Masterson • Aug. 14, 2018 -
Telling doctors about their patients' opioid deaths curbed prescriptions
A letter from the San Diego County medical examiner resulted in lower high-intensity prescribing, fewer opioid prescriptions and overall lower opioid intake, according to an analysis.
By Les Masterson • Aug. 13, 2018 -
Primary care docs easier to find in ACA plans than Medicaid, study finds
Physicians are even more likely to participate in employer-sponsored health plans, according to the Health Affairs report.
By Les Masterson • Aug. 13, 2018 -
In first, FDA approves RNA interference drug from Alnylam
Alnylam's drug, called Onpattro, will carry an average annual list price of $450,000, although the biotech expects rebates to bring the net price down by a fifth.
By Ned Pagliarulo • Updated Aug. 10, 2018 -
FDA OKs marketing of contraceptive app
The Natural Cycles app has generated controversy in Europe, where women have reported unplanned pregnancies while using it.
By Susan Kelly • Aug. 13, 2018 -
CMS proposes Medicare ACO revamp to force risk
Proposed changes to the Medicare Shared Savings Program, a cornerstone of the Affordable Care Act, would force accountable care organizations to take on risk sooner. Critics fear this will chase participants out of the program.
By Tony Abraham • Aug. 10, 2018 -
Massachusetts fumbles on telehealth parity bill
Last year, the American Telemedicine Association gave the state an F on telehealth parity.
By Meg Bryant • Aug. 9, 2018 -
Montgomery County Planning Commission
AMA charges CVS-Aetna deal would reduce competition
The analysis came as Bloomberg reported that the Justice Department won't oppose the merger based on vertical competition issues, although it may still be looking at how it will affect the pharmacy market.
By Les Masterson • Aug. 9, 2018 -
Getty / Edited by Healthcare Dive
CHS under EHR meaningful use investigation
The Franklin, Tennessee-based provider is the latest to face scrutiny from federal investigators regarding the use of EHRs.
By Rebecca Pifer Parduhn • Aug. 9, 2018 -
CVS rejects pharma claim that rebates push up drug prices
Responding to charges that PBMs pocket much of drug rebates, the pharmacy giant said it retains only 2% of the price concessions from drugmakers.
By Ned Pagliarulo • Aug. 9, 2018
Previous
